Capegard (Capecitabine) – 500 Mg

✅ Key Benefits

• Oral administration for convenience over IV 5‑FU

• Tumor‑targeted action with selective activation in cancer cells

• Widely studied and effective across multiple solid tumors

• When combined with other agents (e.g., oxaliplatin, irinotecan), enhances treatment efficacy

🎯 How to Use

• Common regimen: 1250 mg/m² twice daily on days 1–14 of a 21-day cycle, per oncologist’s guidance

• Take within 30 minutes after a meal, with a full glass of water

• Swallow tablets whole; don’t crush or chew

• Follow scheduled treatment cycles, with periodic CBC, renal, and hepatic monitoring

• Dose adjustments may be needed for side effects or renal impairment

⚠️ Precautions

• Prescription-only; specialist supervision mandatory

• Monitor CBC, liver function, and renal function before and during treatment

• Use caution in renal impairment—dose adjustments often required

• Pregnancy category D—avoid in pregnancy or breastfeeding

• Assess risk of hand-foot syndrome and manage promptly

🤕 Possible Side Effects

• Common: Diarrhea, nausea, vomiting, fatigue

• Dermatologic: Hand-foot syndrome (palmar-plantar erythema)

• Hematologic: Anemia, neutropenia, thrombocytopenia

• Gastrointestinal: Abdominal pain, stomatitis

• Serious (rare): Severe GI toxicity, cardiac issues (angina), renal failure—seek urgent care if symptoms arise

❓ Frequently Asked Questions (FAQs)

Q. Who can take Capegard?
A. Patients with colon, metastatic colorectal, breast, or gastric cancer, based on oncologist endorsement.

Q. How long is each cycle?
A. Typical course is 14 days on treatment followed by a 7-day rest period, repeated every 3 weeks—can vary per protocol.

Q. How to manage hand-foot syndrome?
A. Use emollients, avoid tight shoes, reduce dose if symptoms persist, and inform your care team.

Q. Is dose adjustment needed for kidney issues?
A. Yes, moderate to severe renal impairment may require reduced dosage or alternate regimens.